Last updated: December 12, 2023
Sponsor: University Hospital, Strasbourg, France
Overall Status: Active - Recruiting
Phase
N/A
Condition
Covid-19
Treatment
N/AClinical Study ID
NCT06167980
8520
Ages 1-18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Subject aged from 1 month to 18 years
- Hospitalized for Covid-19 in conventional service, continuing care or intensive carefor Covid-19 or in whom SARS-CoV-2 infection was strongly suspected during the allatperiod from January 1, 2020 to December 31, 2021
- Subject who has not expressed, after information, his opposition to the reuse of hisdata for the purposes of this research
- Parental authority having not expressed, after information, their opposition to thereuse of their data for the purposes of this research.
Exclusion
Exclusion Criteria:
- Subject or their parental authority having expressed their opposition to participatingin the study
Study Design
Total Participants: 100
Study Start date:
January 17, 2022
Estimated Completion Date:
December 31, 2023
Study Description
Connect with a study center
Centre de Ressources et de Compétences de la Mucoviscidose (CRCM) - CHU de Strasbourg - France
Strasbourg, 67091
FranceActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.